Phosphoric Acid

Phosphoric Acid

SCHEMBL525246

O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].[Ca+2].[Ca+2].[Ca+2].[Cu+2].[Cu+2].[Cu+2].[Na+].[Na+].[Na+]

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.40
SLC34A1 Q06495 1/20 0.39
KDM4E B2RXH2 1/20 0.33
CYP2C19 P33261 1/20 0.33
KMT2A Q03164 1/20 0.33
CA1 P00915 2/20 0.32
CA4 P22748 2/20 0.32
CA5A P35218 2/20 0.32
CA5B Q9Y2D0 2/20 0.32
FDPS P14324 1/20 0.31
MAPT P10636 1/20 0.30
BLM P54132 1/20 0.30
PMP22 Q01453 1/20 0.30
CYP2C9 P11712 1/20 0.30
TSHR P16473 1/20 0.30
ALOX12 P18054 1/20 0.30
NFKB1 P19838 1/20 0.30
MAPK1 P28482 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL29908532 1.00
Phosphoric Acid SCHEMBL29903884 0.94
Phosphoric Acid SCHEMBL4996071 0.94
Phosphoric Acid SCHEMBL6568574 0.94 SLC34A1 (0.42) LMNASLC34A1MAPT
Phosphoric Acid SCHEMBL28084880 0.94 LMNA (0.43) LMNASLC34A1KDM4ECYP2C19KMT2A
Phosphoric Acid SCHEMBL1681241 0.94 LMNA (0.43) LMNASLC34A1KDM4ECYP2C19KMT2A
Phosphoric Acid SCHEMBL597691 0.94 LMNA (0.43) LMNASLC34A1KDM4ECYP2C19KMT2A
Phosphoric Acid SCHEMBL1138667 0.94
Phosphoric Acid SCHEMBL468673 0.94
Phosphoric Acid SCHEMBL23529389 0.89

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3610865-B1 COMPOSITION COMPRISING BENZOIC ACID AMIDE COMPOUND AND CYCLODEXTRIN SOLUBILIZING AGENT AMOREPACIFIC CORP (KR) 2023-07-12 EP claimed
US-11673071-B2 Isotopic compositions BOTANICAL WATER TECHNOLOGIES IP LTD (GB) 2023-06-13 US claimed
US-11654094-B2 Composition comprising benzoic acid amide compound and cyclodextrin solubilizing agent AMOREPACIFIC CORPORATION (KR) 2023-05-23 US claimed
EP-2881143-B1 Hair colouring method NOXELL CORP (US) 2021-04-07 EP claimed
US-20210093532-A1 COMPOSITION COMPRISING BENZOIC ACID AMIDE COMPOUND AND CYCLODEXTRIN SOLUBILIZING AGENT AMOREPACIFIC CORPORATION (KR) 2021-04-01 US claimed
EP-3610865-A1 COMPOSITION COMPRISING BENZOIC ACID AMIDE COMPOUND AND CYCLODEXTRIN SOLUBILIZING AGENT Amorepacific Corporation (KR) 2020-02-19 EP claimed
US-9468278-B2 Hair colouring methods and kits thereof THE PROCTER & GAMBLE COMPANY (US) 2016-10-18 US claimed
EP-3036009-A1 HAIR COLOURING METHODS AND KITS THEREOF The Procter & Gamble Company (US) 2016-06-29 EP claimed
US-9358201-B2 Hair colouring methods and kits thereof THE PROCTER & GAMBLE COMPANY (US) 2016-06-07 US claimed
EP-2881143-A2 Hair colouring methods and kits thereof The Procter and Gamble Company (US) 2015-06-10 EP claimed
US-20150053228-A1 Hair Colouring Methods and Kits Thereof WELLA OPERATIONS US, LLC 2015-02-26 US claimed
WO-2015026994-A1 HAIR COLOURING METHODS AND KITS THEREOF THE PROCTER & GAMBLE COMPANY (US) 2015-02-26 WO claimed
WO-2015026991-A2 HAIR COLOURING METHODS AND KITS THEREOF THE PROCTER & GAMBLE COMPANY (US) 2015-02-26 WO claimed
US-20150053230-A1 Hair Colouring Methods and Kits Thereof WELLA OPERATIONS US, LLC 2015-02-26 US claimed
EP-3515571-B1 ISOTOPIC COMPOSITIONS BOTANICAL WATER TECH IP LTD (GB) 2026-01-07 EP disclosed
US-20250340743-A1 Polyetheramine-Based Multifunctional Booster TROY TECH II INC (US) 2025-11-06 US disclosed
EP-4535999-A1 POLYETHERAMINE-BASED MULTIFUNCTIONAL BOOSTER COMPOSITIONS Troy Technology II, Inc. (US) 2025-04-16 EP disclosed
WO-2012172318-A1 FORMULATIONS CONTAINING TROPOLONOIDS, COPPER SALT AND A SOLVENT SYSTEM EVOCUTIS PLC (GB) 2012-12-20 WO disclosed
WO-2012085559-A1 ANTIBACTERIAL OR ANTI-ACNE FORMULATIONS CONTAINING USNIC ACID OR AN USNATE AND A METAL SALT EVOCUTIS PLC (GB) 2012-06-28 WO disclosed
WO-2012013967-A2 NEW USES SYNTOPIX GROUP PLC (GB) 2012-02-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150053228-A1 Hair Colouring Methods and Kits Thereof COXFA4L2, ALPG, NACA LMNA 1096/4885SLC34A1 3660/4885KDM4E 2410/4885
US-20210093532-A1 COMPOSITION COMPRISING BENZOIC ACID AMIDE COMPOUND AND CYCLODEXTRIN SOLUBILIZING AGENT CEL, ABCG2, TBCA LMNA 3750/4885SLC34A1 557/4885KDM4E 3550/4885
US-11654094-B2 Composition comprising benzoic acid amide compound and cyclodextrin solubilizing agent CEL, ABCG2, TBCA LMNA 3750/4885SLC34A1 557/4885KDM4E 3550/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.